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ABSTRACT 
 
Opioid abuse has become a public health crisis over the last two decades.  Hydrocodone is the 
most frequently prescribed opioid to patients whose deaths are related to prescription drug abuse.  
On October 6, 2014, Federal law changed hydrocodone, an opioid-based analgesic, from 
Schedule III to Schedule II.  This limits the number of ways it can be prescribed, including 
eliminating refills. This study examined hydrocodone and oxycodone prescriptions written 
across all dental clinics associated with the University of Kentucky College of Dentistry and 
analyzed three different dental disciplines that perform procedures that require pain management.  
Prescription data was obtained through axiUm, the College of Dentistry’s electronic health 
record.  The amount of hydrocodone as morphine milligram equivalents, number of pills, and 
number of prescriptions were assessed via a two-sided t-test to determine whether or not the 
legislation had a significant impact on hydrocodone and oxycodone prescription writing.  
Significant reductions of 27.4% of prescriptions per procedure and 26.0% of pills per procedure 
were noted among all UKCD faculty.  No significant changes were seen with oxycodone 
prescription writing.  Oral Surgery saw a significant reduction in two of the three categories: 
prescriptions per procedure and pills per procedure.  General Dentistry saw a significant rise in 
decision to change hydrocodone from a Schedule III to Schedule II drug impacted the 
prescription writing habits of University of Kentucky College of Dentistry providers by reducing 
the overall amount of hydrocodone written across the college, however the impact within 
different specialties varied. 
 
Key Words: opioids, dentistry, hydrocodone, DEA schedule 
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INTRODUCTION 
 
 
Opioid abuse has become a public health crisis over the last two decades (1). Studies have shown 
that hydrocodone is the most frequently prescribed opioid to patients whose deaths are related to 
prescription drug abuse (2).  On October 6, 2014, federal law changed hydrocodone, an opioid-
based analgesic, from Schedule III to Schedule II (3).  This changed the number of ways it can 
be prescribed, including eliminating refills.  Preliminary data shows that it has helped reduce the 
number of hydrocodone prescriptions nationally among most medical services (4).  However, the 
impact of the change failed to curb hydrocodone prescriptions by dentists at a similar level to 
other medical specialties (4).  This is significant, as dentists account for 9.8% of opioid 
prescriptions (4).  Questions exist concerning the long-term effect the schedule change has had 
on hydrocodone prescription writing in dentistry and whether the change in hydrocodone 
scheduling has had an effect on prescribing oxycodone.   This study examined hydrocodone and 
oxycodone prescriptions written across all dental clinics associated with the University of 
Kentucky College of Dentistry, identifying any change in prescription writing before and after 
the change in scheduling. The study also provided the opportunity to analyze prescription writing 
practices across the dental specialties.   
 
Prescription data was obtained through axiUm, the College of Dentistry’s electronic health 
record.  The amount of hydrocodone, number of pills, and number of prescriptions were assessed 
via a two-sided t-test to determine if the difference between hydrocodone prescription writing 
before and after the schedule change was significant.  Any change in oxycodone prescriptions 
were noted as well.  Provider numbers were used to establish the specialty of the prescribing 
doctor.  Results of each were be compared to address the research questions. 
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Background 
Opioids 
Opioids are a class of drugs derived from opium that are most frequently used as pain killers.  
This includes commonly used prescription drugs such as fentanyl, hydrocodone, and oxycodone, 
as well as illegal drugs such as heroin (5).  Morphine is the prototype opioid analgesic.  
Oxycodone and hydrocodone are semisynthetic congeners of morphine and share its ability to 
produce analgesia and some level of sedation and anxiety relief (6).  Both drugs are very 
effective at treating moderate to severe pain, especially aching-type pain that is often produced 
post-dental surgery.  Opioid-based analgesics come with significant side effects.  Side effects are 
dose dependent and include respiratory depression, constipation, gastrointestinal spasm, and 
dependence (6).  Opioid toxicity can involve an altered mental state, central nervous system 
depression, peripheral vasodilation, pulmonary edema, hypotension, bradycardia, and seizures 
(7).  Respiratory depression is the most serious side effect.  Tidal volume and respiratory rate 
both decrease under the influence opioids.  A respiratory rate of 16 to 18 breaths per minute can 
drop to 3 to 4 shallow breaths per minute.  This is a life-threating situation.  Respiratory 
depression is typically the cause of death in opioid overdoses (6). Overuse can lead to both 
physical and mental dependence, as well as tolerance.  As tolerance increases it takes a higher 
dose of the drug to achieve the same effect.  The lethal dose can be significantly higher in a 
tolerant patient.  However, there is always a lethal dose regardless of the tolerance level of the 
person. (6). 
 
U.S. drug overdoses have been on the rise for four decades, and opioid overdoses have played a 
significant role in their rise (1). U.S. sales of prescription opioids quadrupled from 1999 to 2010 
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(7).  Data shows that opioid analgesics were involved in 30% of all drug overdose deaths in 
1999, and that number increased to 60% by 2010 (1).  Over the last decade the crisis has 
intensified.  Total opioid overdoses have nearly doubled.  This includes overdose increases in 
natural and semisynthetic opioids such as hydrocodone, synthetic opioids like fentanyl, and 
heroin (see Figure 1).  In 2015, 33,000 Americans died of an opioid overdose (8). 
   
           Figure 1. 
 
 
The cause of the epidemic of opioid abuse and overdose is multifactorial.  At the provider level, 
clinical practices and insufficient oversight fail to curb inappropriate prescribing habits.  Many 
insurance policies do not cover safer, more expensive alternatives. At the patient level, many 
people maintain a view that prescription drugs are not harmful, thus leading to overuse (1).  In 
reality, as many as 21% to 29% of chronic pain patients misuse opioids (9). Prescription opioids 
have also been identified as a gateway drug for heroin, as 80% of heroin users first misused 
opioids (10).  
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Opioids in the Commonwealth of Kentucky 
Kentucky continues to be heavily affected by opioid abuse.  Current opioid abuse and overdoses 
have reached a level of crisis (11).  Kentucky has taken steps to prevent opioid abuse.  In 2012, 
the Kentucky General Assembly passed House Bill 1 (HB1) mandating the use of Kentucky All 
Schedule Prescription Electronic Reporting (KASPER).  KASPER is a statewide electronic 
prescription tracking system that allows providers to access the patient’s prescription history to 
better identify potential abuse and drug seeking behavior, focusing on abuse of Schedule II and 
III narcotics (12).  In 2015, the Kentucky Cabinet for Health and Family Services submitted an 
overview of the effects of House Bill 1 (13).  The impact evaluation aimed to evaluate HB1 on 
reducing prescription drug abuse and unlawful transfer in Kentucky, identify unintended 
consequences associated with implementation of HB1, and develop recommendations to improve 
effectiveness of HB1 and mitigate unintended consequences (13).   
 
The impact evaluation deemed KASPER was successful.  Opioid prescriptions decreased from 
2012 to 2015 (13).   “Doctor shopping” behavior dropped by 50% (13).  “Doctor shopping” was 
defined as a patient receiving multiple prescriptions from four or more different prescribers or 
from four or more different pharmacies within a three-month period.  Despite the improvements, 
Kentucky is still dealing with an opioid crisis.  Figure 2 shows that in the first quarter of 2010, 
there were 242 emergency department visits related to opioid overdose.   Opioids such as 
hydrocodone and oxycodone accounted for 207 overdoses and heroin accounted for 35 
overdoses.  By the third quarter of 2013 heroin accounted for 281 overdoses and other opioids 
accounted for 256.  The last reported data in the 3rd quarter of 2016 revealed 1428 heroin 
overdoses and 465 overdoses from other opioids.  In seven years, the overdose rate for heroin has 
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gone up 40-fold and other opioids 2.25-fold.  Overall, emergency department opioid overdoses 
went from 242 to 1893 (14).  As previously stated, 80% of heroin users first misuse opioids.  It is 
clear that more extensive measures need to be implemented to curb access to prescription 
opioids.  
 
                        Figure 2. 
 
 
Federal Regulations of Opioids 
The opioid epidemic isn’t isolated to Kentucky.  It exists to some extent in all regions of the 
U.S., both urban and rural.  Before October 2014, the United States Drug Enforcement 
Administration (DEA) had the two major sources of over-the-counter prescription opioids 
scheduled differently.  Oxycodone was a Schedule II, while hydrocodone was a Schedule III.  
There are significant differences between Schedule II and Schedule III drugs as seen in Table 1. 
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(15).  The major differences are that Schedule II drugs have a higher abuse potential, require a 
written prescription, and cannot be refilled. 
 
Table 1. 
Schedule II Schedule III 
High abuse liability Lower abuse liability 
Require a written prescription Can be called in with a DEA number 
No refills Up to 5 refills in 6 months 
Oxycodone, Hydrocodone and combinations 
currently 
Hydrocodone and combinations prior to 
October 6th, 2014 
  
 
On October 6, 2014, the DEA changed hydrocodone and hydrocodone combination analgesics 
from Schedule III to Schedule II in an effort to curb the amount of hydrocodone being prescribed 
(3).  The overall effect on the medical community has been positive by reducing opioid 
prescriptions (4).  In 2016, Jones et al. published “Effect of US Drug Enforcement 
Administration’s Rescheduling of Hydrocodone Combination Analgesic Products on Opioid 
Analgesic Prescribing.” This brief article in the Journal of the American Medical Association 
analyzed prescription data from an IMS Health Inc. national prescription audit.  It accounted for 
80% of the retail-filled prescriptions of hydrocodone combination drugs in the United States 
during the time frame of the study. The authors charted both the number of prescriptions and 
tablets filled quarterly from 10/1/2011 through 9/30/2015 (3 years prior and 1 year after 
rescheduling).  Nationally, within the medical community, there was an increase in oxycodone 
prescription writing although it wasn’t enough to offset the impact of the reduction in 
hydrocodone prescriptions (4).   Nine medical specialties saw an average reduction in the 
number of hydrocodone prescriptions of 19.3%.  The number of pills prescribed was reduced by 
an average of 15.0%. However, dentistry only reported reductions of 5.7% and 2.0%, 
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respectively (4). The scope of the paper did not include an explanation for the difference with 
dentistry, but it did identify a trend that needed to be further studied. 
 
Purpose  
This study assessed hydrocodone combination prescriptions and oxycodone combination 
prescriptions written across all dental clinics associated with the University of Kentucky College 
of Dentistry. The primary goal of this study was to identify any significant changes in 
prescription writing before and after the change in scheduling.  The secondary goal of the study 
was to assess prescription writing practices across the dental specialties.  
 
Literature Review 
 
The following review of the literature is a summary of the current status of opioid prescription 
writing in the dental field with interest in the appropriateness of opioid prescription writing 
within general dentistry and its effectiveness, its impact on the public, and information on opioid 
legislation.  This foundation is key in understanding the effect of legislation changes, as well as 
establishing a gap in literature where this study can contribute information. Works cited were 
collected from peer reviewed journals searched on PubMed in addition to official statements 
from national and state public health authorities (i.e. the Center for Disease Control or Kentucky  
 
The PubMed terms searched were: “"dentistry" and "opioids"”.  The search yielded 258 journal 
articles (n = 258).  Articles were eliminated based on a number of requirements: 133 did not 
directly relate to dental opioid management (n = 125), 97 were older than 10 years (n = 28), and 
3 were not published in English (n = 25).  The search yielded 25 relevant articles. 
 12 
A second literature search containing terms “dentistry” AND “opioid” AND “legislation” tallied 
18 articles (n = 18).  Articles eliminated included: Seven papers older than ten years (n = 13), 
and 3 papers not directly related to dental opioid management and policy regulation (n = 10). 
 
In summary, the literature reviews identified 35 total relevant articles.  The first search yielded 
25 articles dealing with prescription writing habits, appropriateness, and its effect on patients and 
the public.  This ranged from the role and impact of dentists in prescribing opioids (16 - 17) to 
the value of opioids versus NSAIDs post oral surgery (18).  Ten additional articles identified in 
the second literature search generally cover opioid management and legislation within dentistry.  
This includes topics such as how to apply laws in your practice (19) to the impact of prescription 
drug monitoring programs (20 - 22). 
 
The literature review established the appropriateness of opioid prescription writing in dentistry 
(23) with key articles that discuss the actual opiate prescription writing habits of dentists (24) 
and the role dentists play in the opioid crisis (25).  The review of the literature articulates the 
important role dentists play in opioid prescription writing, and it affirms the topic is worth 
investigation in the face of an opioid abuse crisis within the U.S. 
 
Gaps in the literature exist.  The difference between the role of hydrocodone and oxycodone in 
the prescription writing habits of dentists isn’t thoroughly discussed.  None expounded upon the 
trend identified in the foundation article (4) that the DEA rescheduling of hydrocodone had less 
of an impact on dentistry than other specialties.  Lastly, there is no information on the impact of 
policy on the prescription writing habits of different specialties within dentistry.  The gaps in the 
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literature provide a place for a study that looks at the impact of legislation on dental opioid 
prescription writing among general dentists and dental specialties.  This research project can fill 
that gap assessing the impact of the rescheduling of hydrocodone on a small scale, via study of 
the dental practitioners at the University of Kentucky College of Dentistry (UKCD). 
 
METHODS 
 
 
The collection of data required approval from the University of Kentucky Institutional Review 
Board (IRB).  IRB number 44700 “UKCD Opioid Prescription Writing” was approved and a 
Medical Expedited IRB through the University of Kentucky Office of Research Integrity was 
granted on 7/22/2018.  The information was gathered by designing a custom report on axiUm, 
UKCD’s electronic health record.  The needed report was run in axiUm through the following 
steps: 
"Actions" tool bar option 
“Info Manager” drop down option 
“Clinical” tab 
“Prescription” category 
“Predefined” option 
Select “Taylor Rx Search” 
 
Data in the following fields were collected:  
 “Rx date” 10/4/12 – 10/4/17 
 “Rx drug” all brand and generic versions of hydrocodone and oxycodone 
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 “Rx dose” the amount of hydrocodone and oxycodone 
 “Rx total” the number of pills prescribed  
 “Dr. provider number” The provider’s identification number in axiUm 
 “Dr. first name” 
 “Dr. last name” 
 
Prescription data were collected, exported into Microsoft Excel, and sorted to assess the needed 
information.  Initial data tested included all UKCD providers sorted into types according to their 
practice.  The following categories were used: General Dentistry (included all general dentists, 
prosthodontists, and endodontists), Oral Surgery, Periodontal Surgery, and Orofacial Pain. The 
data was analyzed by quarter spanning Q4 of 2012 through Q3 of 2017.  Total pills written and 
total prescriptions written per quarter were analyzed.  This revealed sharp rises in opioid 
prescription writing throughout that time.  The data were reassessed for other potential variables.  
 
It was hypothesized that, due to a change in administration, the number of clinic procedures and 
patients seen at the school had increased substantially as a way to financially compensate for 
continued cuts in state funding.  A second report was run to identify the total number of 
procedures likely to require opioid analgesia per quarter.  The procedures were identified through 
the billing Code on Dental Procedures and Nomenclature (CDT code).  This included all oral 
surgery procedures, periodontal surgical procedures, endodontic procedures, and implant-related 
procedures.  This change required dropping Orofacial Pain as a provider type, because they 
charge through medical codes as opposed to CDT codes.  Medical codes cannot be tracked 
through axiUm.  This cut represented 5.4% of all the prescriptions written in the given time 
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frame.  However, the elimination of Orofacial Pain makes practical sense as its practice functions 
under a medical model to treat chronic pain issues.  Very few dentists practice within this model 
of care.  Most orofacial chronic pain patients are treated at universities where a specially-trained 
dentist works in conjunction with physical therapy, neurology, psychology, and psychiatry to 
treat patients.  All collected data was reanalyzed without Orofacial Pain for consistency.  
References to “all UKCD faculty” reflects this change. 
 
The new data were collected quarterly.  Pills per procedure, prescriptions per procedure, and 
morphine milligram equivalents (MME) were analyzed.  MMEs represent the equivalent amount 
of morphine written by taking prescription type and dosage into account. They are calculated for 
hydrocodone and oxycodone as follows:  
Hydrocodone MME = (dosage x 1) x # of pills 
Oxycodone MME = (dosage x 1.5) x # of pills 
In this study, MMEs per prescription were calculated. This was accomplished by taking the sum 
of the MMEs of all prescriptions written per quarter and dividing by the total opioid 
prescriptions written per quarter: 
 
MMEs per prescription   =           Total quarter MMEs 
                                                       # of quarter opioid prescriptions 
 
Graphical evaluation of the data revealed consistent prescriber patterns that continued through 
the end of 2015.  Trends in prescription writing rose considerably after the beginning of 2016 
skewing the data beyond what the scope of this paper is attempting to analyze, i.e. a significant 
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change in payer type due to Medicaid expansion.  For the purposes of analyzing the 2014 
rescheduling of hydrocodone, data were considered through year end 2015. 
Total pills per procedure, prescriptions per procedure, and MMEs per prescription from 
10/4/2012 through 10/4/14 (date of the schedule change) and 10/5/14 through 12/31/15 were 
calculated quarterly.  Total UKCD faculty data were compared as well as the previously defined 
General Practice, Oral Surgery, and Periodontal Surgery disciplines.  Data were analyzed via a 
two-tailed t-test.  Significance was defined as a p-value of < .05. The null hypothesis was that 
there will not be a significant change in prescription writing practices. This was tested for both a 
significant increase or decrease. 
 
 
RESULTS 
 
 
The following Figures 3, 4, and 5 are graphical representations of prescription writing for all 
UKCD faculty.  The vertical line on each graph represents the date of the DEA schedule change. 
Figure 3 is the graphical representation of MMEs per prescription.  Table 2 summarizes the 
results of the two-tailed t-test comparing MMEs before and after the schedule change.  The test 
produced a p-value of .8045.  The result failed to reject the null hypothesis that there would not 
be a significant change in MMEs after the change in scheduling.  This is consistent with the 
0.71% increase described by the raw data. 
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         Figure 3. 
 
Figures 4 and 5 represent the trends in hydrocodone prescriptions per procedure and 
hydrocodone pills per procedure respectively for all UKCD faculty.  Both prescriptions per 
procedure and pills per procedure were analyzed via a two-tailed t-test producing p-values of 
.0349 and .0039 respectively.  The results of the tests are listed in Table 2.  Here, the null 
hypothesis that there would be no change in prescription writing behavior is rejected.  Both p-
values are less than .05 indicating significance.   The numerical raw data and graphic evidence 
confirms that there was a significant reduction.  Prescriptions per procedure were reduced by 
27.4%, while pills per procedure were reduced by 26.0% 
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                    Figure 4. 
 
 
 
 
                    Figure 5. 
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Table 2.  
UKCD Total P-value Percent Change 
MMEs per prescription .8045 +0.7 
Prescriptions per procedure .0349 -27.4 
Pills per procedure .0039 -26.0 
 
Oxycodone prescriptions were also analyzed for all UKCD faculty.  Oxycodone prescriptions 
accounted for 8.7% of the total hydrocodone and oxycodone prescriptions and 7.9% of total 
hydrocodone and oxycodone pills. There was no significant change in number of prescriptions or 
pills of oxycodone written after the DEA schedule change of hydrocodone through year-end 
2015. 
 
MMEs per prescription, prescriptions per procedure, and pills per procedure were assessed 
across the applicable dental specialties:  General Dentistry, Oral Surgery, and Periodontal 
Surgery.  A two-tailed t-test was performed for each category comparing the change in 
prescription writing habits from Q4 of 2012 to the schedule change and from the schedule 
change to year-end 2015.  P-value results failed to reject the null hypothesis in the following 
circumstances identified in Table 3:  General Dentistry, Periodontal Surgery, and Oral Surgery 
MMEs per prescription, Periodontal Surgery prescriptions per procedure, and General Dentistry 
and Periodontal Surgery pills per procedure.  All presented with a p-value > .05.  Table 3 shows 
the null hypothesis was rejected in the following circumstances:  Oral Surgery pills per 
prescription and General Dentistry and Oral Surgery prescriptions per procedure.  All presented 
with a p-value < .05.  The raw data supports that there was a significant difference in prescription 
writing habits in the aforementioned categories.  General Dentistry prescriptions per procedure 
increased by 31.2%. Oral Surgery prescriptions per procedure and pills per procedure were 
reduced by 38.3% and 31.8% respectively. 
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Table 3. 
 MMEs per 
prescription p-value 
Prescriptions per 
procedure p-value 
Pills per procedure p-
value 
General Dentistry .1151 .0459 (+31.2%) .4265 
Oral Surgery .1347 .0151 (-38.3%) .0343 (-31.8%) 
Periodontal Surgery .4759 .3094 .4808 
When statistically significant, % change listed in parentheses  
 
 
DISCUSSION 
 
 
It is apparent that the legislation had an effect on the prescription writing habits of University of 
Kentucky dentists.  The data suggests providers wrote fewer prescriptions per procedure and 
fewer total pills per procedure. However, there was no significant change in the MMEs per 
prescription. This would indicate that of the prescriptions that were written, the dosages and pills 
were consistent despite the schedule change. 
 
Significant reductions in prescribing by provider type varied.  Oral Surgery saw a significant 
reduction in two of the three categories: prescriptions per procedure and pills per procedure.  
General Dentistry saw a significant rise in prescriptions per procedure, while Periodontal 
Surgery saw no significant changes.  Oral Surgeons account for 53.4% of hydrocodone and 
oxycodone prescriptions written and 62.8% of the hydrocodone and oxycodone pills dispensed at 
UKCD.  Their behavior change would have the most impact on the total data for the college.  
Opioid prescription writing is also a larger part of their practice than Periodontal Surgeons and 
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General Dentists due to the nature of the procedures they perform and how frequently they 
perform them.  Jones hypothesized that the major reduction in opioid prescriptions written in 
medical practices nationwide is due to fewer refills (4). While most dental procedures are 
outpatient and don’t require long term pain management, oral surgeons also perform operating 
room procedures that would necessitate opioid refills.  Therefore, the regulation of these refills 
could have a greater effect on Oral Surgery than other specialties. While some general dentists 
treat long term pain issues, long term pain management is not a day-to-day part of most general 
dental practices. 
 
Periodontal Surgery did not show a significant change in any of the categories.  This is likely 
because many of their procedures are focused on small areas of the oral cavity and do not require 
the same amount of pain management as procedures typically done by oral surgeons.  It’s 
reasonable to conclude that Periodontal Surgery was already prescribing the minimal amount of 
opioids that is practical for the procedures they perform. 
  
General Dentistry prescriptions per procedure increased by 31.2%.  Identifying the cause for this 
increase could be beyond the scope of this paper, however some speculative causes have been 
identified. While it is possible that general dentists at UKCD are writing more opioid 
prescriptions since the rescheduling, the lack of increase in pills per procedure makes this 
assumption less likely.  The scheduling change eliminated the ability to write refills or call in 
prescriptions for hydrocodone, and this could encourage a provider to write prescriptions more 
often to avoid additional follow up appointments.  Also at UKCD during the time frame of the 
study, there was an increase in the number of extractions covered by general dentists in the 
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student and urgent care clinics. This led to general dentists covering more procedures that require 
post-operative pain control with opioids. For example, the percent of surgical extractions covered 
by general practitioners increased from 8.5% of extractions before the schedule change to 11.6% 
after the schedule change. Finally, for acute pain that cannot be treated by a general dentist, a 
referral to an oral surgeon is often the protocol. It is common practice for general practitioners to 
prescribe an opioid to manage a patient’s pain until an appointment with an oral surgeon can be 
arranged. Each of these factors could be contributing to the increase in prescriptions per 
procedure by general dentists at UKCD. 
 
It is possible that the overall reductions evidenced by the data are not singularly due to the 
stricter management of prescription writing habits created by the legislation. The change in 
scheduling is part of a larger, multifaceted effort to increase the awareness of the role providers 
play in the escalating opioid crisis. This may have led to a change in provider behavior through a 
change in their perspective on the drug and its dangers.  This indicates that UKCD dentists 
possibly changed their opioid prescribing habits as a public service, not due to the effects of 
added regulation. 
CONCLUSION 
 
The DEA’s decision to change hydrocodone from a Schedule III to Schedule II drug impacted 
the prescription writing habits of University of Kentucky College of Dentistry providers by 
reducing the amount of hydrocodone per procedure written across the college.  It is possible that 
this is due to UKCD providers being more cognizant of the need for a public health intervention 
as opposed to the effects of the regulation change itself.  Future studies need to address the 
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discrepancy in MMEs versus the number of pills and prescriptions being written at that time.  As 
previously mentioned in the paper, there is an increasing trend in opioid prescription writing 
from 2016 to the present among UKCD providers.  There are many variables that need to be 
assessed, such as a changes in payer base associated with Medicaid expansion and its effects on 
treatment planning and procedures.  Much could also be learned by assessing changes in 
provider attitude toward prescribing opioids over time within the college and at the state and 
national level. 
 
LIMITATIONS 
The sample size is small so the impact on the scheduling change could be masked by other 
variables, i.e. changes in administration, payer base, new faculty, faculty calibration, and 
procedure type.  We were unable to analyze Orofacial Pain due to their billing procedures.  The 
timeframe was also shortened due to an unexplained spike in opioid prescriptions written in 2016 
and 2017. 
 
 
IMPLICATIONS FOR PUBLIC HEALTH 
 
This empirical study utilized primary data to fulfill essential public health services in the 
following ways:   Primarily, it supported essential public health service #9, by evaluating the 
effectiveness and quality of personal and population-based health services (26).  It did this by 
identifying opioid prescription writing habits of a sizable provider population during what has 
been described by the media and health authorities as an opioid crisis.  It also supported essential 
public health service #5 by analyzing policy intended to support community health efforts (26). 
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The study assessed the prescriptions, pills written, and morphine milligram equivalents, before 
and after a federal policy change.   
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